This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Implicit parasitic Sepsis
AB1_SEPSIS_PARAS_IMPL_WIDE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditions
|
61648 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
209 |
4. Check minimum number of eventsNone |
209 |
5. Include endpointsNone |
209 |
6. Filter based on genotype QC (FinnGen only) |
203 |
Control definitions (FinnGen only)
- Control exclude
- AB1_SEPSIS_EXPLICIT, AB1_SEPSIS_IMPLICIT
Extra metadata
- First used in FinnGen datafreeze
- DF13
Similar endpoints
↥List of similar endpoints to
Implicit parasitic Sepsis
based on the number of shared cases.
Similar with more cases:
- Implicit Sepsis
- Condition for Implicit Sepsis (Organ dysfunction codes)
- Condition for Implicit Sepsis (Organ dysfunction codes)
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 203 | 118 | 85 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 55.22 | 51.38 | 60.56 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 209
- Matched controls
- 2090
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R55
ICD-10 Finland
Syncope and collapse
36.7
144.2
106
57
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
11.8
47.8
56
63
A07.8
ICD-10 Finland
Other specified protozoal intestinal diseases
364.5
31.7
31
*
AA1AD
NOMESCO Finland
CT of head and brain
5.1
29.9
95
292
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
4.9
25.5
76
218
N17.9
ICD-10 Finland
Acute renal failure, unspecified
90.0
22.2
24
*
A07.1
ICD-10 Finland
Giardiasis [lambliasis]
220.0
19.9
20
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.8
19.8
130
632
P01AB01
ATC
metronidazole; oral, rectal
3.7
19.7
124
586
A06.9
ICD-10 Finland
Amoebiasis, unspecified
+∞
19.0
18
*
J01MA12
ATC
levofloxacin; systemic
4.1
18.9
67
214
TPH04
NOMESCO Finland
Cathetrisation of vein
3.8
17.6
71
247
R51.80
ICD-10 Finland
Headache
3.8
16.4
63
211
R06.0
ICD-10 Finland
Dyspnoea
3.4
16.1
86
356
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.0
16.1
56
175
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.2
15.3
104
495
XF400
NOMESCO Finland
ECG with 12 standard connections
3.8
15.2
57
187
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.3
14.3
43
120
R50.9
ICD-10 Finland
Fever, unspecified
3.8
14.0
51
163
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
14.0
83
361
A06AC01
ATC
ispaghula (psylla seeds); oral
3.2
14.0
77
321
C03CA01
ATC
furosemide; systemic
3.1
13.8
81
350
A07.9
ICD-10 Finland
Protozoal intestinal disease, unspecified
149.3
13.6
14
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.3
13.5
24
42
XF402
NOMESCO Finland
ECG with work load test
4.3
12.8
37
100
N30.0
ICD-10 Finland
Acute cystitis
3.6
12.6
49
163
A41.9
ICD-10 Finland
Sepsis, unspecified
137.9
12.6
13
*
R42
ICD-10 Finland
Dizziness and giddiness
3.2
12.5
67
272
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.4
12.5
57
210
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
6.0
11.9
22
40
A02BC05
ATC
esomeprazole; systemic
2.8
11.8
107
575
D64.9
ICD-10 Finland
Anaemia, unspecified
4.1
11.8
36
101
N17
ICPC
Vertigo/dizziness
4.0
11.8
38
111
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.3
11.8
25
52
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.1
11.6
36
102
XF404
NOMESCO Finland
Ambulatory ECG
4.4
11.6
32
83
A10AB05
ATC
insulin aspart; parenteral
4.9
11.6
27
61
N05BA01
ATC
diazepam; systemic, rectal
3.6
11.6
44
144
A59.0
ICD-10 Finland
Urogenital trichomoniasis
+∞
11.6
11
*
UJF32
NOMESCO Finland
Coloscopy
3.0
11.5
70
304
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.9
11.4
27
62
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.5
11.3
46
157
C03DA01
ATC
spironolactone; oral
3.9
11.3
38
114
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
5.3
11.3
24
50
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
11.2
47
164
H02AB06
ATC
prednisolone; systemic
2.7
11.2
117
671
Z2221
NOMESCO Finland
Medical doctor
2.8
11.0
77
359
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
11.0
67
290
N03AX09
ATC
lamotrigine; oral
6.0
10.9
20
36
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.3
10.8
47
167
N05CF01
ATC
zopiclone; oral
2.7
10.8
89
451
R5140
NOMESCO Finland
Monitoring the use of the aid
3.7
10.8
39
123
J01FF01
ATC
clindamycin; systemic
2.8
10.8
74
342
E0000UV, ,
ATC
2.6
10.8
107
595
R53
ICD-10 Finland
Malaise and fatigue
2.8
10.5
72
331
A06.0
ICD-10 Finland
Acute amoebic dysentery
+∞
10.5
10
*
B54
ICD-10 Finland
Unspecified malaria
+∞
10.5
10
*
R4110
NOMESCO Finland
Physiotherapy
2.7
10.5
78
375
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.6
10.4
26
62
D06
ICPC
Abdominal pain localized other
4.3
10.3
29
76
N06AX21
ATC
duloxetine; oral
3.5
10.3
39
127
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.7
10.0
34
103
Z3226
NOMESCO Finland
Physiotherapist
2.9
9.8
57
239
J01MA06
ATC
norfloxacin; oral
3.3
9.8
42
148
A04
ICPC
Weakness/tiredness general
3.1
9.6
46
173
N05AH04
ATC
quetiapine; oral
3.0
9.5
50
198
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
3.6
9.5
34
106
J96.1
ICD-10 Finland
Chronic respiratory failure
104.6
9.5
10
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
9.4
59
258
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.6
9.3
78
394
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.5
9.2
35
114
N05CD07
ATC
temazepam; oral
3.4
9.2
37
125
I95.9
ICD-10 Finland
Hypotension, unspecified
38.5
9.1
11
*
A11
ICPC
Chest pain NOS
3.8
9.0
29
84
S06.0
ICD-10 Finland
Concussion
3.4
8.8
35
117
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.2
8.8
25
66
N02AA05
ATC
oxycodone; systemic
2.9
8.8
49
200
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
7.5
8.8
20
29
UJF30
NOMESCO Finland
Ileoscopy through colon
3.4
8.6
34
113
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.4
8.6
34
113
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.9
8.6
27
77
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.2
8.6
38
136
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
5.2
8.5
18
37
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
8.5
92
518
1369X
ICD-9 Finland
Other and unspecified infectious and parasitic diseases, Unspecified infectious and parasitic diseases
+∞
8.4
8
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
+∞
8.4
8
*
A28
ICPC
Limited function/disability NOS
2.9
8.3
44
174
J01MA02
ATC
ciprofloxacin; systemic
2.4
8.3
95
546
WX892
NOMESCO Finland
Monitored bed care
4.1
8.3
24
64
103
Kela drug reimbursment
Diabetes, insulin-treated
2.6
8.3
64
308
N02AX02
ATC
tramadol; systemic, rectal
2.3
8.3
101
597
A02BC01
ATC
omeprazole; systemic
2.5
8.2
69
345
C07AB07
ATC
bisoprolol; oral
2.3
8.2
115
720
Z71.8
ICD-10 Finland
Other specified counselling
2.4
8.2
81
436
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.2
8.2
23
60
T36
ICD-10 Finland
Poisoning by systemic antibiotics
7.8
8.2
18
25
N03AX16
ATC
[U] pregabalin
2.6
8.2
60
282
127
Kela drug reimbursment
Transplant complication
34.8
8.2
10
*
A06AD11
ATC
lactulose; oral
3.1
8.1
38
140
WX002
NOMESCO Finland
Sedation and analgesia
2.7
8.1
53
235
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
4.1
8.0
23
61
Z50.1
ICD-10 Finland
Other physical therapy
5.0
8.0
18
39
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
7.5
8.0
18
26
E86
ICD-10 Finland
Volume depletion
11.4
7.9
14
13
JN4AD
NOMESCO Finland
Body CT examination
3.5
7.9
29
92
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.8
7.8
18
40
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.6
7.8
53
239
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.4
7.8
30
98
N06AX11
ATC
mirtazapine; oral
2.3
7.7
84
470
J02AC01
ATC
fluconazole; systemic
2.3
7.7
96
569
R11
ICD-10 Finland
Nausea and vomiting
3.4
7.6
29
94
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
6.9
7.6
18
28
N05CF02
ATC
zolpidem; oral
2.7
7.6
47
202
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.5
7.6
28
89
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.0
7.6
37
140
H04.10
ICD-10 Finland
Dry eye syndrome
3.0
7.6
38
146
K59.09
ICD-10 Finland
Constipation, unspecified
3.9
7.5
23
64
A10AC01
ATC
insulin (human); parenteral
3.8
7.5
24
69
R06AE07
ATC
cetirizine; oral
2.2
7.4
106
661
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.7
7.4
48
211
WX402
NOMESCO Finland
General anaesthesia
2.6
7.4
52
238
R02
ICPC
Shortness of breath/dyspnoea
3.1
7.4
34
124
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.6
7.4
49
218
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.7
7.4
24
70
B58.9
ICD-10 Finland
Toxoplasmosis, unspecified
+∞
7.3
7
*
J96.0
ICD-10 Finland
Acute respiratory failure
+∞
7.3
7
*
A06.8
ICD-10 Finland
Amoebic infection of other sites
+∞
7.3
7
*
M79.6
ICD-10 Finland
Pain in limb
2.2
7.3
100
613
L28
ICPC
Limited function/disability (L)
2.7
7.2
45
194
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
7.1
99
609
N06AA09
ATC
amitriptyline; systemic
3.2
7.1
30
104
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.6
7.1
50
229
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
3.3
7.1
28
93
A10AE05
ATC
insulin detemir; parenteral
4.3
7.1
19
48
B01AA03
ATC
warfarin; systemic
2.6
7.0
47
210
A10AE04
ATC
insulin glargine; parenteral
3.4
7.0
26
83
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
7.0
30
105
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
14.4
7.0
11
8
TAB00
NOMESCO Finland
Lumbar puncture
4.4
7.0
18
44
R07.4
ICD-10 Finland
Chest pain, unspecified
2.3
7.0
68
361
N06AB10
ATC
escitalopram; oral
2.5
6.9
51
238
N05AX08
ATC
risperidone; systemic
3.3
6.9
27
89
W19
ICD-10 Finland
Unspecified fall
3.3
6.9
27
89
D11
ICPC
Diarrhoea
2.9
6.9
36
141
N03AE01
ATC
clonazepam; systemic
4.2
6.9
19
49
K59.1
ICD-10 Finland
Functional diarrhoea
4.0
6.8
20
54
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.8
6.8
16
25
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.3
6.8
18
45
N03AG01
ATC
valproic acid; systemic, rectal
4.1
6.7
19
50
ZX120
NOMESCO Finland
Intravenous
3.1
6.7
29
102
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.6
6.6
23
70
SPAT1229
SPAT
Assessment of need for aid
3.7
6.6
22
65
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
6.1
6.6
17
30
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
6.1
6.6
17
30
J45.9
ICD-10 Finland
Asthma, unspecified
2.5
6.6
47
216
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.4
6.5
56
281
B50.9
ICD-10 Finland
Plasmodium falciparum malaria, unspecified
72.0
6.5
7
*
H32.0*B58.0
ICD-10 Finland
Toxoplasma chorioretinitis
72.0
6.5
7
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.2
6.4
74
418
K92.1
ICD-10 Finland
Melaena
4.1
6.4
18
47
N05BA04
ATC
oxazepam; oral
2.3
6.4
65
349
A02BC03
ATC
lansoprazole; oral
2.2
6.4
69
380
Z2446
NOMESCO Finland
Social worker
3.5
6.4
23
72
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.3
6.3
55
276
N06AX16
ATC
venlafaxine; oral
2.7
6.3
38
160
N05AH03
ATC
olanzapine; systemic
3.7
6.3
21
62
L04AA06
ATC
mycophenolic acid; systemic
18.7
6.3
9
5
L04AA01
ATC
[U] ciclosporin
18.7
6.3
9
5
Z94.0
ICD-10 Finland
Kidney transplant status
+∞
6.3
6
*
A41.8
ICD-10 Finland
Other specified sepsis
+∞
6.3
6
*
M54.4
ICD-10 Finland
Lumbago with sciatica
2.5
6.3
46
214
C07AB02
ATC
metoprolol; systemic
2.4
6.2
48
228
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
2.1
6.2
124
860
H04AA01
ATC
glucagon; nasal, parenteral
8.1
6.2
13
17
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.1
6.2
27
95
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.5
6.2
22
68
N02BF02
ATC
pregabalin; oral
3.7
6.2
20
58
I20.99
ICD-10 Finland
Angina pectoris, unspecified
3.7
6.2
20
58
N03AX12
ATC
[U] gabapentin; oral
2.5
6.2
43
195
I50.9
ICD-10 Finland
Heart failure, unspecified
2.8
6.2
34
137
I50.1
ICD-10 Finland
Left ventricular failure
5.9
6.1
16
29
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
6.1
48
230
C07AG02
ATC
carvedilol; oral
3.6
6.0
20
59
I50.0
ICD-10 Finland
Congestive heart failure
3.6
6.0
20
59
F32.1
ICD-10 Finland
Moderate depressive episode
3.6
6.0
20
59
E000001, ,
ATC
2.3
6.0
52
260
Z3231
NOMESCO Finland
Registered nurse
2.2
6.0
70
396
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
55
61
11.88
47.35
3.3
1.5
—
—
—
0
0
77
172
6.50
35.53
7.5
3.8
1.10
1.03
mmol/l
0.91
71
156
45
87
6.32
23.41
2.3
1.5
—
—
—
0
0
31
47
7.57
20.18
1.5
1.5
1.03
7.43
ug/l
0.49
25
38
49
121
4.98
19.29
5.9
2.8
1.45
2.13
mmol/l
0.59
44
97
142
764
3.68
17.79
12.6
5.1
1.21
1.22
mmol/l
1.26
127
644
133
700
3.48
16.98
10.4
4.3
1.20
1.22
mmol/l
1.90
128
631
149
854
3.59
16.29
10.0
5.6
10.30
10.83
umol/l
0.47
144
803
158
944
3.76
16.07
8.8
3.5
6.80
6.57
mmol/l
0.60
150
865
125
660
3.22
15.36
7.0
3.7
34.33
36.20
g/l
2.84
119
620
114
575
3.16
15.10
4.7
2.6
—
—
—
0
0
97
447
3.18
15.01
4.6
2.6
0.21
0.32
e6/l
0.56
71
329
68
259
3.41
14.36
3.7
3.1
545.92
164.60
ng/l
0.74
52
198
58
203
3.57
13.95
3.4
1.9
2.22
2.38
g/l
1.26
52
185
55
186
3.66
13.93
3.5
2.0
18.70
23.17
%
1.57
48
166
59
210
3.52
13.81
3.1
1.7
—
—
—
0
0
136
803
2.99
12.86
10.9
5.4
27.82
28.19
%
0.16
126
763
99
503
2.84
12.29
3.5
2.1
53.13
68.16
u/l
0.91
87
456
116
640
2.83
12.29
2.7
1.9
102.77
91.93
pmol/l
1.46
66
314
60
232
3.22
12.16
3.4
1.9
10.91
13.91
umol/l
1.84
54
211
133
793
2.86
12.05
10.2
5.2
57.30
56.88
%
0.16
125
752
99
508
2.80
12.00
4.9
2.7
31.39
29.72
u/l
0.19
94
485
43
136
3.72
11.91
3.0
1.6
—
—
—
0
0
43
137
3.69
11.77
2.9
1.6
—
—
—
0
0
44
143
3.63
11.69
12.7
4.9
1.41
1.08
mmol/l
0.21
38
117
80
379
2.80
11.15
1.9
1.5
17.80
21.48
nmol/l
1.59
70
308
178
1290
3.56
10.54
12.2
6.6
73.39
77.60
u/l
1.05
171
1190
73
342
2.74
10.27
2.6
1.8
1.29
1.01
mg/l
0.36
61
265
60
256
2.88
10.05
4.0
2.4
3.01
0.98
e6/l
0.40
30
149
113
661
2.54
10.00
2.9
2.2
76.58
76.10
nmol/l
0.07
106
573
57
237
2.93
10.00
4.2
2.6
3.90
2.21
e6/l
0.32
27
130
44
158
3.26
9.93
2.9
2.6
6.33
7.06
umol/l
0.26
38
134
147
979
2.69
9.82
13.6
9.2
4.22
3.99
e9/l
0.45
130
869
15
10
16.03
9.67
2.3
1.3
—
—
—
0
0
120
733
2.50
9.53
4.3
2.6
107.76
100.73
ug/l
0.18
113
672
15
11
14.57
9.33
2.3
1.4
—
—
—
0
0
32
98
3.67
9.20
4.3
2.9
93.05
80.25
ng/l
0.37
22
85
86
458
2.49
9.12
4.2
2.9
1263.85
1244.31
ng/l
0.02
74
380
63
289
2.69
9.10
1.9
1.6
948.12
1188.77
nmol/l
1.51
46
210
34
111
3.46
8.88
4.1
2.4
64.56
67.18
g/l
1.32
28
105
77
395
2.50
8.79
1.5
1.2
0.96
1.30
u/ml
0.19
14
109
76
388
2.51
8.76
2.9
1.8
2.60
2.95
mg/l
0.87
70
325
30
93
3.60
8.45
4.8
2.3
1.81
1.66
mmol/l
0.07
23
72
30
94
3.56
8.32
1.9
1.3
—
—
—
0
0
22
55
4.35
8.30
1.6
1.2
—
—
—
0
0
14
12
12.40
8.20
2.3
1.4
—
—
—
0
0
16
18
9.52
8.20
2.6
1.8
—
—
—
0
0
20
47
4.60
8.14
1.9
1.3
314.14
314.59
ug/g
0.00
14
31
44
178
2.86
7.99
14.0
4.8
104.55
103.91
mmol/l
0.37
44
178
17
23
7.94
7.85
2.8
1.7
—
—
—
0
0
17
23
7.94
7.85
2.6
1.7
—
—
—
0
0
44
180
2.83
7.82
1.8
1.6
1.63
1.46
%
0.57
36
151
13
11
12.51
7.69
2.8
1.5
—
—
—
0
0
21
54
4.21
7.64
1.6
1.2
—
—
—
0
0
18
28
6.93
7.60
1.9
1.7
—
—
—
0
0
24
69
3.80
7.52
2.3
1.7
—
—
—
0
0
73
390
2.34
7.42
4.4
2.7
343.97
4101.13
umol/l
1.23
61
336
19
47
4.35
7.25
1.4
1.2
—
—
—
0
0
100
614
2.21
7.23
5.3
3.5
46.37
43.11
ng/l
0.07
78
410
23
67
3.73
7.07
2.9
2.1
1.59
1.39
g/l
0.45
23
55
92
555
2.17
6.87
4.1
3.0
2.31
2.35
mmol/l
2.15
85
490
37
149
2.80
6.73
2.3
1.9
350.90
370.86
nmol/l
0.26
30
137
12
13
9.71
6.38
2.0
1.5
—
—
—
0
0
163
1256
2.35
6.24
6.3
3.7
14.20
10.91
mm/h
1.46
155
1141
148
1099
2.19
6.18
4.8
2.8
51.29
41.84
u/l
0.48
141
1028
13
18
7.62
6.02
2.2
1.9
—
—
—
0
0
119
822
2.04
5.94
6.1
3.4
0.00
0.00
estimate
-0.00
26
159
13
19
7.22
5.83
2.2
1.9
—
—
—
0
0
13
19
7.22
5.83
2.2
1.9
—
—
—
0
0
13
19
7.22
5.83
2.2
1.9
—
—
—
0
0
118
816
2.02
5.83
8.6
4.5
0.00
0.00
estimate
-0.00
28
166
21
66
3.43
5.77
2.3
2.1
1.04
1.16
%
0.26
21
66
117
809
2.01
5.76
6.2
3.4
0.03
0.00
estimate
0.49
29
177
107
718
2.00
5.72
19.8
12.0
1.27
1.24
inr
0.12
30
223
12
16
7.88
5.72
2.3
1.4
—
—
—
0
0
13
20
6.85
5.65
2.2
1.8
—
—
—
0
0
13
20
6.85
5.65
2.2
1.8
—
—
—
0
0
19
58
3.50
5.45
1.2
2.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
30
5.30
5.37
3.9
1.9
0.37
0.34
u/ml
—
8
14
9
8
11.68
5.34
2.2
1.6
—
—
—
0
0
160
1262
2.14
5.20
4.6
3.9
14.69
14.78
pmol/l
0.17
148
1133
32
137
2.58
5.14
2.6
2.2
9.94
6.47
ug/l
0.62
27
115
8
6
13.79
5.12
1.5
1.8
—
—
—
0
0
8
6
13.79
5.12
1.5
1.8
—
—
—
0
0
15
41
3.86
5.02
1.3
1.3
—
—
—
0
0
196
1708
3.37
4.79
32.6
11.5
24.71
21.83
mg/l
0.59
166
1306
14
30
4.92
4.78
1.7
1.3
—
—
—
0
0
140
1071
1.93
4.72
4.0
3.1
—
—
—
0
0
13
26
5.26
4.71
1.5
1.2
—
—
—
0
0
9
11
8.49
4.61
2.1
1.5
—
—
—
0
0
12
23
5.47
4.53
1.3
1.2
393.33
180.38
u/ml
—
6
8
15
37
4.29
4.51
3.3
2.2
—
—
—
0
0
56
321
2.02
4.50
2.0
1.7
471.98
456.17
pmol/l
0.14
49
263
25
101
2.68
4.49
1.0
1.0
—
—
—
0
0
74
469
1.89
4.43
5.0
3.4
13.66
7.39
mg/mmol
0.57
52
279
15
45
3.51
4.41
1.6
1.2
—
—
—
0
0
7
6
12.01
4.30
1.6
1.8
—
—
—
0
0
7
6
12.01
4.30
1.6
1.8
—
—
—
0
0
14
41
3.59
4.26
1.4
1.4
0.14
0.25
iu/ml
—
5
11
21
80
2.81
4.21
1.6
1.4
—
—
—
0
0
182
1557
2.31
4.12
6.2
4.6
1.96
2.71
mu/l
0.46
175
1395
14
36
4.09
4.08
2.7
4.6
62.41
211.53
mg/l
0.42
14
30
14
36
4.09
4.08
2.7
4.6
42.19
27.81
mg/l
0.81
14
30
9
14
6.66
4.03
2.1
1.4
—
—
—
0
0
9
14
6.66
4.03
2.6
1.5
—
—
—
0
0
14
43
3.42
3.98
1.1
1.1
—
—
—
0
0
62
383
1.88
3.95
4.0
2.2
—
—
—
0
0
14
38
3.87
3.88
5.8
2.1
24.11
24.98
mmol/l
0.26
14
38
14
44
3.34
3.85
5.1
2.3
8.34
8.56
kpa
0.24
14
44
6
5
12.30
3.78
2.2
1.8
—
—
—
0
0
6
5
12.30
3.78
2.2
1.8
—
—
—
0
0
48
277
1.95
3.73
1.2
1.2
30.71
30.76
iu/ml
—
7
86
9
16
5.82
3.70
1.0
1.1
—
—
—
0
0
53
320
1.88
3.60
3.5
2.8
2.41
2.44
mmol/l
1.79
47
287
6
6
10.24
3.52
2.2
1.7
—
—
—
0
0
6
6
10.24
3.52
1.8
2.0
75.00
94.00
%
—
6
6
20
82
2.59
3.50
21.0
5.7
0.69
0.70
%
0.07
20
82
20
83
2.56
3.42
20.5
5.7
1.42
1.43
%
0.01
20
83
12
33
3.79
3.35
2.6
2.2
35.86
176.33
ug/min
—
7
20
6
7
8.78
3.28
3.3
1.1
—
—
—
0
0
6
7
8.78
3.28
3.3
1.1
—
—
—
0
0
11
29
3.94
3.23
2.1
1.3
—
—
—
0
0
15
55
2.86
3.23
2.9
1.7
—
—
—
0
0
8
15
5.50
3.22
3.1
1.7
—
—
—
0
0
8
15
5.50
3.22
3.1
1.7
—
—
—
0
0
12
35
3.57
3.16
3.4
3.2
204.58
194.00
%
0.12
12
35
6
8
7.68
3.07
1.8
1.8
—
—
—
0
0
101
760
1.64
3.06
4.4
2.4
—
—
—
0
0
5
5
10.20
2.99
1.0
1.4
—
—
—
0
0
5
5
10.20
2.99
2.6
1.8
—
—
—
0
0
182
1609
2.02
2.96
28.0
11.5
78.19
82.56
ml/min/173m2
1.42
148
1303
8
17
4.85
2.95
1.0
1.1
—
—
—
0
0
66
455
1.66
2.78
6.4
3.6
0.00
0.00
estimate
-0.00
28
160
7
14
5.13
2.75
3.6
2.0
—
—
—
0
0
196
1793
2.50
2.74
34.4
13.8
85.93
75.01
umol/l
1.91
196
1793
170
1482
1.79
2.74
32.8
14.2
14.69
14.93
%
0.24
170
1461
7
15
4.79
2.62
3.0
1.5
701.00
659.93
e6/l
—
7
15
7
15
4.79
2.62
1.0
1.1
—
—
—
0
0
42
260
1.77
2.59
1.2
1.2
2.75
7.28
u/ml
1.00
12
108
5
7
7.28
2.56
1.6
2.0
15.00
11.00
u/l
—
5
7
5
7
7.28
2.56
3.8
1.4
—
—
—
0
0
5
7
7.28
2.56
3.8
4.6
818.20
1077.29
u/ml
—
5
7
5
7
7.28
2.56
1.0
1.7
26.20
30.43
umol/l
—
5
7
5
7
7.28
2.56
1.0
1.1
—
—
—
0
0
5
7
7.28
2.56
1.0
1.1
—
—
—
0
0
6
11
5.58
2.56
1.0
1.0
—
—
—
0
0
6
11
5.58
2.56
4.0
2.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
8
6.37
2.38
1.0
1.3
—
—
—
0
0
6
13
4.72
2.29
1.2
1.2
—
—
—
0
0
31
182
1.83
2.27
3.5
2.1
—
—
—
0
0
14
60
2.43
2.27
2.6
1.9
—
—
—
0
0
8
25
3.28
2.11
1.1
1.7
—
—
—
0
0
8
25
3.28
2.11
1.3
1.1
—
—
—
0
0
5
10
5.09
2.08
1.0
2.7
50.40
107.60
nmol/l
—
5
10
174
1563
1.68
2.07
7.6
5.4
40.50
39.46
mmol/mol
0.69
166
1451
8
27
3.04
1.95
1.9
1.5
—
—
—
0
0
8
28
2.93
1.88
1.3
1.4
—
—
—
0
0
8
28
2.93
1.88
1.3
1.4
—
—
—
0
0
5
12
4.24
1.83
1.4
1.0
—
—
—
0
0
27
163
1.75
1.82
8.3
3.0
—
—
—
0
0
82
644
1.45
1.81
6.9
3.4
—
—
—
0
0
7
162
0.41
1.76
1.0
1.7
—
—
—
0
0
6
18
3.40
1.76
1.2
1.1
—
—
—
0
0
7
24
2.98
1.74
1.0
1.1
—
—
—
0
0
5
13
3.91
1.72
1.6
1.8
—
—
—
0
0
5
13
3.91
1.72
1.2
1.0
—
—
—
0
0
5
13
3.91
1.72
1.6
1.8
—
—
—
0
0
5
13
3.91
1.72
1.6
1.8
—
—
—
0
0
6
19
3.22
1.67
4.0
4.9
—
—
—
0
0
6
19
3.22
1.67
2.2
2.3
108.33
105.42
mmol/l
—
6
19
179
1643
1.62
1.67
5.5
4.3
6.17
5.87
mmol/l
1.61
162
1492
10
41
2.51
1.67
7.7
1.9
—
—
—
0
0
45
318
1.53
1.65
1.6
1.5
—
—
—
0
0
193
1808
1.88
1.65
18.0
9.5
27.53
25.15
u/l
0.36
186
1737
31
201
1.64
1.63
3.8
2.2
—
—
—
0
0
5
15
3.39
1.53
1.4
1.2
—
—
—
0
0
5
16
3.17
1.44
17.0
12.2
7.30
6.15
mmol/l
—
5
10
58
445
1.42
1.41
1.9
1.6
1.50
1.37
mmol/l
0.41
50
372
5
17
2.99
1.36
1.2
1.1
91.60
90.06
%
—
5
17
15
83
1.87
1.35
4.9
1.7
—
—
—
0
0
6
24
2.54
1.31
2.3
1.3
0.29
0.32
nmol/l
—
6
17
6
24
2.54
1.31
1.2
1.1
—
—
—
0
0
173
1599
1.48
1.31
4.5
3.9
1.33
1.27
mmol/l
0.57
159
1453
5
18
2.82
1.29
1.2
1.1
—
—
—
0
0
5
18
2.82
1.29
1.4
1.2
—
—
—
0
0
8
36
2.27
1.25
1.1
1.4
—
—
—
0
0
181
1694
1.51
1.22
5.8
4.9
2.56
2.77
mmol/l
2.47
170
1552
5
19
2.67
1.22
1.0
1.3
—
—
—
0
0
5
19
2.67
1.22
1.0
1.3
—
—
—
0
0
17
103
1.71
1.17
5.1
1.8
—
—
—
0
0
5
20
2.54
1.16
1.0
1.3
—
—
—
0
0
5
20
2.54
1.16
1.0
1.3
—
—
—
0
0
5
20
2.54
1.16
1.0
1.3
—
—
—
0
0
5
21
2.41
1.09
1.4
1.1
—
—
—
0
0
5
21
2.41
1.09
1.2
1.1
106.40
109.19
%
—
5
21
5
23
2.20
0.98
1.6
1.3
—
—
nmol/l
—
0
0
176
1658
1.39
0.95
5.1
4.4
4.35
4.68
mmol/l
3.58
163
1533
6
27
2.26
0.94
1.7
1.4
—
—
—
0
0
175
1648
1.38
0.93
5.0
4.3
1.41
1.48
mmol/l
1.26
160
1510
10
57
1.79
0.85
2.1
1.7
—
—
—
0
0
197
1904
1.60
0.81
45.8
17.7
39.62
40.31
%
1.23
190
1806
10
58
1.76
0.81
1.4
2.1
—
—
—
0
0
197
1908
1.57
0.74
44.8
17.8
130.79
135.83
g/l
4.45
197
1875
7
39
1.82
0.73
1.3
1.8
—
—
—
0
0
5
30
1.68
0.62
1.0
1.1
—
—
—
0
0
6
37
1.64
0.56
2.2
1.6
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
34
304
1.14
0.24
2.3
3.0
0.55
0.70
ug/l
0.81
27
196
24
211
1.16
0.22
15.5
6.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
83.74
—
0
11
0
11
0.00
0.21
0.0
1.1
—
31.52
—
0
11
15
127
1.20
0.20
2.4
2.8
54.67
65.84
ml/min/173m2
—
9
49
44
422
1.05
0.08
3.3
4.5
23.85
21.64
%
0.23
14
198
26
255
1.02
0.00
1.7
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
7.99
—
0
6
5
58
0.86
-0.00
1.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
96.60
—
0
5
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_SEPSIS_PARAS_IMPL_WIDE – Implicit parasitic Sepsis
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).